In the current session, Yunhong CTI Inc. (NASDAQ:CTIB) is trading at $6.43, after a 183.48% increase. Over the past month, the stock increased by 439.55%, and in the past year, by 97.53%. With ...
CTI Plans Marketing Authorization Application Filing in Europe This Year SEATTLE, July 14, 2010 /PRNewswire via COMTEX/ -- Cell Therapeutics ("CTI") (Nasdaq and MTA: CTIC) today announced that it has ...
The Bresso facility was formerly NovusPharma, a spin out of Roche/Boehringer Mannheim, which CTI acquired in 2004. About Cell Therapeutics, Inc. Headquartered in Seattle, CTI is a biopharmaceutical ...
MARKHAM, ONTARIO and INDIANAPOLIS, INDIANA--(Marketwired - Oct 19, 2015) - Enghouse Systems Limited (ESL.TO) ("Enghouse") and CTI Group (Holdings) Inc. ("CTI") (CTIG) jointly announced that they have ...
SEATTLE, Sept. 24 Cell Therapeutics, Inc. (CTI)(Nasdaq and MTAX: CTIC) today announced that Richard L. Love has joined itsboard of directors. Love was the Chairman of the Board for Systems ...
CARY, N.C., Nov. 15, 2022 /PRNewswire/ -- CTI Towers, Inc. ("CTI Towers"), a leading owner and manager of wireless towers, today announced the acquisition of 180 towers located in 14 states from Uniti ...
(MENAFN- PR Newswire) Thirty-fifth US location in Allentown, PA adds industry-leading Network Operation Center and Control Room practice to CTI's portfolio ALLENTOWN, Pa., Feb. 13, 2024 /PRNewswire/ - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results